STOCK TITAN

Repligen Announces Publication of the Company’s 2023 Corporate Sustainability Report

Rhea-AI Impact
(No impact)
Rhea-AI Sentiment
(Positive)
Tags

Repligen (NASDAQ:RGEN) has published its 2023 Corporate Sustainability Report, titled 'Advancing Impacts.' The report outlines progress across six key impact areas: Products & Packaging, Operations, Talent, Supply Chain, Communities, and Partnerships & Pathways.

Key achievements include:

  • Expansion of 100% renewable electricity to 13 of 18 manufacturing sites (88% of global consumption)
  • Increase in women in management positions from 27% to 29%
  • 68% reduction in Scope 2 emissions from 2022 to 2023
  • 60% increase in productivity savings through Repligen Performance System
  • Commitment to net-zero emissions by 2050 with Science Based Targets initiative

The report aligns with major reporting frameworks including GRI Standards, SASB, UN SDGs, and TCFD, and serves as Repligen's 2023 Communication on Progress for the UN Global Compact.

Repligen (NASDAQ:RGEN) ha pubblicato il suo Rapporto sulla Sostenibilità Aziendale 2023, intitolato 'Avanzare gli Impatti.' Il rapporto delinea i progressi in sei aree chiave di impatto: Prodotti e Imballaggi, Operazioni, Talenti, Catena di Fornitura, Comunità e Partnership e Percorsi.

I risultati principali includono:

  • Espansione dell'elettricità rinnovabile al 100% in 13 dei 18 siti di produzione (88% del consumo globale)
  • Aumento delle donne in posizioni di gestione dal 27% al 29%
  • Riduzione del 68% delle emissioni di Ambito 2 dal 2022 al 2023
  • Incremento del 60% nei risparmi di produttività attraverso il Sistema di Prestazioni Repligen
  • Impegno a raggiungere emissioni nette di carbonio zero entro il 2050 con l'iniziativa Science Based Targets

Il rapporto è in linea con i principali framework di rendicontazione tra cui GRI Standards, SASB, UN SDGs e TCFD, e funge da comunicazione di progresso di Repligen per il 2023 per il Patto Globale delle Nazioni Unite.

Repligen (NASDAQ:RGEN) ha publicado su Informe de Sostenibilidad Corporativa 2023, titulado 'Avanzando los Impactos.' El informe describe los avances en seis áreas clave de impacto: Productos y Envases, Operaciones, Talento, Cadena de Suministro, Comunidades y Alianzas y Caminos.

Los logros clave incluyen:

  • Expansión del 100% de electricidad renovable a 13 de 18 sitios de fabricación (88% del consumo global)
  • Aumento de mujeres en posiciones de gestión del 27% al 29%
  • Reducción del 68% en las emisiones de Alcance 2 de 2022 a 2023
  • Aumento del 60% en ahorros de productividad a través del Sistema de Rendimiento Repligen
  • Compromiso de alcanzar emisiones netas cero para 2050 con la iniciativa Science Based Targets

El informe se alinea con los principales marcos de informes, incluidos los Estándares GRI, SASB, ODS de la ONU y TCFD, y sirve como comunicación de progreso de Repligen para el 2023 para el Pacto Global de la ONU.

Repligen (NASDAQ:RGEN)는 '영향력 향상'이라는 제목의 2023년 기업 지속 가능성 보고서를 발표했습니다. 이 보고서는 제품 및 포장, 운영, 인재, 공급망, 커뮤니티, 파트너십 및 경로 등 6개의 주요 영향 분야에서의 진행 상황을 설명합니다.

주요 성과로는:

  • 18개 제조 사이트 중 13곳에 100% 재생 가능 전기 확대(전 세계 소비의 88%)
  • 관리직 여성 비율 증가: 27%에서 29%로
  • 2022년 대비 2023년 Scope 2 배출량 68% 감소
  • Repligen 성과 시스템을 통한 생산성 절감 60% 증가
  • 2050년까지 탄소 중립 목표를 위한 Science Based Targets 이니셔티브에 대한 약속

이 보고서는 GRI 표준, SASB, UN SDGs 및 TCFD 등 주요 보고 프레임워크와 일치하며, UN 글로벌 콤팩트에 대한 Repligen의 2023년 진행 상황 통보로 기능합니다.

Repligen (NASDAQ:RGEN) a publié son Rapport de Durabilité d’Entreprise 2023, intitulé 'Avancement des Impacts.' Le rapport décrit les progrès réalisés dans six domaines clés : Produits et Emballages, Opérations, Talents, Chaîne d'approvisionnement, Communautés et Partenariats et Voies.

Les réalisations clés incluent:

  • Expansion de l'électricité renouvelable à 100% à 13 des 18 sites de fabrication (88% de la consommation mondiale)
  • Augmentation de la proportion de femmes dans des postes de direction, passant de 27% à 29%
  • Réduction de 68% des émissions de Scope 2 entre 2022 et 2023
  • Augmentation de 60% des économies de productivité grâce au Système de Performance Repligen
  • Engagement à atteindre des émissions nettes nulles d'ici 2050 avec l'initiative Science Based Targets

Le rapport s'aligne sur les principaux cadres de reporting, y compris les Normes GRI, SASB, les ODD de l'ONU et le TCFD, et fait office de communication de progrès de Repligen pour 2023 pour le Pacte Mondial des Nations Unies.

Repligen (NASDAQ:RGEN) hat seinen Unternehmensnachhaltigkeitsbericht 2023 mit dem Titel 'Fortschritte bei den Auswirkungen' veröffentlicht. Der Bericht beschreibt Fortschritte in sechs wichtigen Einflussbereichen: Produkte und Verpackungen, Betrieb, Talente, Lieferkette, Gemeinschaften sowie Partnerschaften und Wege.

Wichtige Erfolge beinhalten:

  • Ausweitung von 100% erneuerbarer Energie auf 13 von 18 Produktionsstandorten (88% des globalen Verbrauchs)
  • Steigerung des Anteils von Frauen in Führungspositionen von 27% auf 29%
  • 68% Rückgang der Scope-2-Emissionen von 2022 bis 2023
  • 60% Steigerung der Produktivitätsersparnisse durch das Repligen Performance System
  • Verpflichtung zu Netto-Null-Emissionen bis 2050 mit der Initiative Science Based Targets

Der Bericht orientiert sich an wichtigen Berichtsstandards, einschließlich GRI Standards, SASB, UN SDGs und TCFD und dient als Kommunikation von Fortschritten von Repligen für das Jahr 2023 für den UN Global Compact.

Positive
  • None.
Negative
  • None.

WALTHAM, Mass., Dec. 12, 2024 (GLOBE NEWSWIRE) -- Repligen Corporation (NASDAQ:RGEN), a life sciences company focused on bioprocessing technology leadership, today announced the digital publication of its 2023 Corporate Sustainability Report and related reporting framework disclosures. Themed “Advancing Impacts”, this newly reformatted report streamlines the company’s progress in advancing our sustainability strategy across six key impact areas: Products & Packaging, Operations, Talent, Supply Chain, Communities and Partnerships & Pathways. Also included in the 2023 Sustainability Report are detailed disclosures aligned with four key reporting frameworks: the Global Reporting Initiative (GRI) Standards, Sustainability Accounting Standards Board (SASB), United Nations Sustainable Development Goals (UN SDGs) and Task Force on Climate-Related Disclosures (TCFD).

Olivier Loeillot, President and Chief Executive Officer at Repligen said, “I am delighted with the progress we’ve made on key sustainability metrics and am pleased to share the positive impacts highlighted in this ambitious annual report. I look forward to continuing to support these important initiatives that reflect our commitment to responsible corporate citizenship.”

Dianne Heiler, Vice President of Sustainability and Global Head of Packaging Engineering at Repligen said, “I’m especially proud to have led the development of this reformatted report and to have submitted our commitment letter to SBTi to lower total GHG emissions in alignment with the latest climate science. This publication also serves as Repligen’s Corporation’s 2023 Communication on Progress in fulfillment of our annual commitment to the UNGC (United Nations Global Compact).”

Below are just a few of the 2023 Sustainability Report highlights across environmental, social and governance topics. Report data is through year end 2023 unless otherwise noted.

Advancing Impacts: Report Highlights

  • Expanded our transition to 100% renewable electricity from 9 to 13 of 18 manufacturing sites, representing 88% of our global consumption.
  • Increased the percentage of women in management, defined as Associate Director and above, from 27% in 2022 to 29% in 2023.
  • Reduced Scope 2 emissions by 68% from 2022 to 2023.
  • Achieved a 60% increase in productivity savings through the Repligen Performance System (RPS) compared to 2022.
  • Committed to net-zero emissions by 2050 with the Science Based Targets initiative (SBTi).

About Repligen Corporation
Repligen Corporation is a global life sciences company that develops and commercializes highly innovative bioprocessing technologies and systems that enable efficiencies in the process of manufacturing biological drugs. We are “inspiring advances in bioprocessing” for the customers we serve; primarily biopharmaceutical drug developers and contract development and manufacturing organizations (CDMOs) worldwide. Our focus areas are Filtration and Fluid Management, Chromatography, Process Analytics and Proteins. Our corporate headquarters are located in Waltham, Massachusetts, and the majority of our manufacturing sites are in the U.S., with additional key sites in Estonia, France, Germany, Ireland, the Netherlands and Sweden. For more information, please visit www.repligen.com, and follow us on LinkedIn.

Forward Looking Statements

This press release may contain forward-looking statements within the meaning of the federal securities laws. Investors are cautioned that statements in this press release which are not strictly historical statements including, without limitation, statements identified by words like “believe,” “expect,” “may,” “will,” “should,” “seek,” or “could” and similar expressions, constitute forward-looking statements. Such forward-looking statements are subject to a number of risks and uncertainties that could cause actual results to differ materially from those anticipated, including risks discussed from time to time in our filings with the Securities and Exchange Commission. We expressly disclaim any responsibility to update any forward-looking statements, except as required by law.

Repligen Contact:
Sondra S. Newman
VP, Global Head of Investor Relations
(781) 419-1881
investors@repligen.com


FAQ

What are the key sustainability achievements in Repligen's (RGEN) 2023 report?

Repligen's key achievements include expanding renewable electricity to 13 manufacturing sites, reducing Scope 2 emissions by 68%, increasing women in management to 29%, and achieving 60% higher productivity savings through RPS.

How much did Repligen (RGEN) reduce its Scope 2 emissions in 2023?

Repligen reduced its Scope 2 emissions by 68% from 2022 to 2023.

What is Repligen's (RGEN) commitment to renewable electricity in 2023?

Repligen expanded its use of 100% renewable electricity from 9 to 13 of 18 manufacturing sites, representing 88% of global consumption.

What is Repligen's (RGEN) long-term environmental goal with SBTi?

Repligen has committed to achieving net-zero emissions by 2050 through the Science Based Targets initiative (SBTi).

How has Repligen (RGEN) improved gender diversity in management for 2023?

Repligen increased the percentage of women in management positions (Associate Director and above) from 27% in 2022 to 29% in 2023.

Repligen Corp

NASDAQ:RGEN

RGEN Rankings

RGEN Latest News

RGEN Stock Data

8.10B
52.34M
6.58%
100.79%
6.11%
Medical Instruments & Supplies
Biological Products, (no Disgnostic Substances)
Link
United States of America
WALTHAM